Stewart Lancaster works in the field of Hematology. He researched medicine at Penn State College of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Stewart L. Lancaster is a published doctor. He has 1 publication published. The most current publication "Phase II Study of Irinotecan and Cetuximab Given Every 2 Weeks as Second-Line Therapy for Advanced Colorectal Cancer." He accepts Medicare payments and is listed with Medicare.gov.
University of Massachusetts
Penn State College of Medicine
UPMC Passavant| NPI NUMBER | 1154392215 | |
| NPPES Provider LastName | LANCASTER | |
| NPPES Provider FirstName | STEWART | |
| NPPES Provider ZIPCode | 150091919 | |
| NPPES Provider State | PA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 1115.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 143.0 | |
| Percent Opioid Claims | 12.83 |
| National Provider Identifier [NPI] | 1154392215 |
| Last Name Of The Provider | LANCASTER |
| First Name Of The Provider | STEWART |
| View All |
|
Dr. Grace R. Tarabay, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Carolyn C. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas W. McCreary III, MD
This Doctor is OpenDoctor Recommended.
|